These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11858979)

  • 41. Achievements and goals of the EORTC Invasive Fungal Infections Group. European Organisation for Research and Treatment of Cancer.
    de Pauw BE; Herbrecht R; Meunier F;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S88-93. PubMed ID: 11858972
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The EORTC soft tissue and bone sarcoma group. European Organisation for Research and Treatment of Cancer.
    Donato Di Paola E; Nielsen OS;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S138-41. PubMed ID: 11858980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis.
    Milecki P; Kwias Z; Martenka DJ
    Neoplasma; 2007; 54(1):7-15. PubMed ID: 17203887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
    Sassowsky M; Gut P; Hölscher T; Hildebrandt G; Müller AC; Najafi Y; Kohler G; Kranzbühler H; Guckenberger M; Zwahlen DR; Azinwi NC; Plasswilm L; Takacs I; Reuter C; Sumila M; Manser P; Ost P; Böhmer D; Pilop C; Aebersold DM; Ghadjar P
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):534-41. PubMed ID: 23972722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group.
    Poortmans P; Bossi A; Vandeputte K; Bosset M; Miralbell R; Maingon P; Boehmer D; Budiharto T; Symon Z; van den Bergh AC; Scrase C; Van Poppel H; Bolla M;
    Radiother Oncol; 2007 Aug; 84(2):121-7. PubMed ID: 17706307
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.
    Peeters ST; Heemsbergen WD; van Putten WL; Slot A; Tabak H; Mens JW; Lebesque JV; Koper PC
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1019-34. PubMed ID: 15752881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [25th meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO)].
    Mazeron JJ
    Bull Cancer; 2006 Dec; 93(12):1241-4. PubMed ID: 17182379
    [No Abstract]   [Full Text] [Related]  

  • 48. New radiation therapy techniques for the treatment of head and neck cancer.
    Ding M; Newman F; Raben D
    Otolaryngol Clin North Am; 2005 Apr; 38(2):371-95, vii-viii. PubMed ID: 15823599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunities.
    van Leeuwen M; Efficace F; Fosså SD; Bolla M; De Giorgi U; de Wit R; Holzner B; van de Poll-Franse LV; van Poppel H; White J; Collette L; Osanto S; Aaronson NK; ; ;
    Eur J Cancer; 2014 Jul; 50(11):1957-63. PubMed ID: 24820932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The quality assurance programme of the Radiotherapy Group of the European Organisation for Research and Treatment of Cancer: past, present and future.
    Poortmans PM; Davis JB; Ataman F; Bernier J; Horiot JC;
    Eur J Surg Oncol; 2005 Aug; 31(6):667-74. PubMed ID: 16100781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of clinical trial protocols involving advanced radiation therapy techniques: the European Organisation for Research and Treatment of Cancer Radiation Oncology Group approach.
    Fairchild A; Bar-Deroma R; Collette L; Haustermans K; Hurkmans C; Lacombe D; Maingon P; Poortmans P; Tomsej M; Weber DC; Gregoire V
    Eur J Cancer; 2012 May; 48(7):1048-54. PubMed ID: 22387181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG).
    Leong T; Smithers BM; Michael M; Gebski V; Boussioutas A; Miller D; Simes J; Zalcberg J; Haustermans K; Lordick F; Schuhmacher C; Swallow C; Darling G; Wong R
    BMC Cancer; 2015 Jul; 15():532. PubMed ID: 26194186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current trials and new aspects in soft tissue sarcoma of adults.
    Issels RD; Schlemmer M
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulatory issues for clinical trials at EORTC: the way forward. European Organisation for Research and Treatment of Cancer.
    Baeyens AJ; Lacombe D
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S142-6. PubMed ID: 11858981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality assurance control in the EORTC cooperative group of radiotherapy. 1. Assessment of radiotherapy staff and equipment. European Organization for Research and Treatment of Cancer.
    Horiot JC; Johansson KA; Gonzalez DG; van der Schueren E; van den Bogaert W; Notter G
    Radiother Oncol; 1986 Aug; 6(4):275-84. PubMed ID: 3095891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting report.
    Thomas G; Eisenhauer E; Bristow RG; Grau C; Hurkmans C; Ost P; Guckenberger M; Deutsch E; Lacombe D; Weber DC;
    Eur J Cancer; 2020 May; 131():76-88. PubMed ID: 32305726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality assurance in surgical oncology (QASO) within the European Organization for Research and Treatment of Cancer (EORTC): current status and future prospects.
    Landheer ML; Therasse P; van de Velde CJ
    Eur J Cancer; 2001 Aug; 37(12):1450-62. PubMed ID: 11506950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quality assurance in radiotherapy: from radiation physics to patient- and trial-oriented control procedures.
    Bernier J; Horiot JC; Poortmans P
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S155-8. PubMed ID: 11858985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allan van Oosterom, President of the EORTC. European Organisation for the Research and Treatment of Cancer. Interview by Jeroen van der Boon.
    van Oosterom A
    Lancet Oncol; 2002 Jan; 3(1):58-61. PubMed ID: 11905607
    [No Abstract]   [Full Text] [Related]  

  • 60. New innovative techniques in radiotherapy for breast cancer.
    Murphy JO; Sacchini VS
    Minerva Chir; 2013 Apr; 68(2):139-54. PubMed ID: 23612227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.